Company / Total Assets
aTYR PHARMA INC Total Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$93.0M
FY2025
5-year range
$93.0M / $120.7M
FY2021-FY2025
Trend
-4.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 7 years, ranging from $36M in FY2019 to $121M in FY2023.
Based on SEC 10-K filings.
$93M in FY2025 with a 5-year CAGR of +19.2%.
Declined from $121M to $93M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -1.0%
- 5-Year CAGR
- +19.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +19.2%, indicating consistent growth.
- In FY2025, total assets decreased 4.0% year-over-year.
- Peak total assets was recorded in FY2023.
- Lowest total assets in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $93.0M | -4.0% |
| FY2024 | $96.8M | -19.7% |
| FY2023 | $120.7M | +26.0% |
| FY2022 | $95.8M | -17.1% |
| FY2021 | $115.5M | +198.3% |
| FY2020 | $38.7M | +7.0% |
| FY2019 | $36.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026